JPWO2020223698A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020223698A5 JPWO2020223698A5 JP2021564270A JP2021564270A JPWO2020223698A5 JP WO2020223698 A5 JPWO2020223698 A5 JP WO2020223698A5 JP 2021564270 A JP2021564270 A JP 2021564270A JP 2021564270 A JP2021564270 A JP 2021564270A JP WO2020223698 A5 JPWO2020223698 A5 JP WO2020223698A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- use according
- agonist
- biomaterial
- innate immunity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024114666A JP2024151337A (ja) | 2019-05-02 | 2024-07-18 | がんの処置 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962842068P | 2019-05-02 | 2019-05-02 | |
| US62/842,068 | 2019-05-02 | ||
| PCT/US2020/031169 WO2020223698A1 (en) | 2019-05-02 | 2020-05-01 | Cancer treatment |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024114666A Division JP2024151337A (ja) | 2019-05-02 | 2024-07-18 | がんの処置 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022531184A JP2022531184A (ja) | 2022-07-06 |
| JP2022531184A5 JP2022531184A5 (https=) | 2023-05-11 |
| JPWO2020223698A5 true JPWO2020223698A5 (https=) | 2023-05-11 |
Family
ID=73029386
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021564270A Pending JP2022531184A (ja) | 2019-05-02 | 2020-05-01 | がんの処置 |
| JP2024114666A Pending JP2024151337A (ja) | 2019-05-02 | 2024-07-18 | がんの処置 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024114666A Pending JP2024151337A (ja) | 2019-05-02 | 2024-07-18 | がんの処置 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220218822A1 (https=) |
| EP (1) | EP3962524A4 (https=) |
| JP (2) | JP2022531184A (https=) |
| KR (1) | KR20220004077A (https=) |
| CN (1) | CN113766929A (https=) |
| AU (1) | AU2020266676A1 (https=) |
| BR (1) | BR112021021699A8 (https=) |
| CA (1) | CA3132653A1 (https=) |
| IL (1) | IL287652A (https=) |
| WO (1) | WO2020223698A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20230041032A (ko) * | 2020-07-17 | 2023-03-23 | 서지 테라퓨틱스, 인크. | 중합체 복합 제제를 포함하는 제제 및 조성물 |
| AU2021329884A1 (en) * | 2020-08-17 | 2023-02-16 | SURGE Therapeutics, Inc. | Immune modulation of myeloid derived suppressive cell function for cancer treatment |
| AU2022212114A1 (en) * | 2021-01-30 | 2023-06-22 | SURGE Therapeutics, Inc. | Cancer therapy |
| KR102906748B1 (ko) * | 2023-05-09 | 2025-12-31 | 국립부경대학교 산학협력단 | 아임계 수 가수분해를 이용한 갑각류 유래 올리고키토산의 제조방법, 이를 이용하여 제조된 올리고키토산 및 올리고키토산을 포함하는 약학적 조성물 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5965379A (en) * | 1991-07-19 | 1999-10-12 | Cytimmune Sciences Inc. | Method for measuring endogenous cytokines |
| EP0820305A2 (en) | 1995-04-04 | 1998-01-28 | Wound Healing of Oklahoma | Cancer treatment by photodynamic therapy, in combination with an immunoadjuvant |
| US6756363B1 (en) | 2000-11-17 | 2004-06-29 | Wound Healing Of Oklahoma, Inc. | Solutions and films of glycated chitosan |
| AU2003243608A1 (en) * | 2002-06-20 | 2004-01-06 | Royer Biomedical, Inc. | Resorbable delivery systems for the treatment of cancer |
| RU2288730C2 (ru) * | 2005-02-22 | 2006-12-10 | Научно-исследовательский институт Эпидемиологии и микробиологии Сибирского отделения Российской академии наук (НИИ ЭМ СО РАМН) | Способ лечения онкогинекологических больных и гель для его осуществления |
| EP1942950A2 (en) * | 2005-11-01 | 2008-07-16 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Biodegradable composite for internal local radiotherapy |
| GB201004575D0 (en) * | 2010-03-19 | 2010-05-05 | Immatics Biotechnologies Gmbh | Composition of tumor associated peptides and related anti cancer vaccine for the treatment of gastric cancer and other cancers |
| EP3831393A1 (en) | 2012-01-20 | 2021-06-09 | Immunophotonics, Inc. | Chitosan-derived compositions |
| US11111316B2 (en) | 2012-01-20 | 2021-09-07 | Immunophotonics, Inc. | Chitosan-derived compositions |
| US20160008399A1 (en) * | 2013-01-14 | 2016-01-14 | Fred Hutchinson Cancer Research Center | Compositions and methods for delivery of immune cells to treat un-resectable or non-resected tumor cells and tumor relapse |
| WO2017024318A1 (en) * | 2015-08-06 | 2017-02-09 | Dana-Farber Cancer Institute, Inc. | Targeted protein degradation to attenuate adoptive t-cell therapy associated adverse inflammatory responses |
| AU2017255833B2 (en) * | 2016-04-25 | 2022-09-01 | Mizhou Hui | Application of small-molecule hyaluronic acid fragment |
| FI3922279T3 (fi) | 2016-08-30 | 2025-02-04 | Dana Farber Cancer Inst Inc | Lääkkeenantokoostumuksia ja niiden käyttötapoja |
| WO2018088933A1 (en) * | 2016-11-14 | 2018-05-17 | Limited Liability Company "Panacela Labs" | Anti-tumor effects of a viral vector encoding a toll-like receptor and a toll-like receptor agonist |
-
2020
- 2020-05-01 CN CN202080032326.6A patent/CN113766929A/zh active Pending
- 2020-05-01 US US17/608,070 patent/US20220218822A1/en active Pending
- 2020-05-01 KR KR1020217036221A patent/KR20220004077A/ko active Pending
- 2020-05-01 WO PCT/US2020/031169 patent/WO2020223698A1/en not_active Ceased
- 2020-05-01 AU AU2020266676A patent/AU2020266676A1/en active Pending
- 2020-05-01 EP EP20798248.9A patent/EP3962524A4/en active Pending
- 2020-05-01 JP JP2021564270A patent/JP2022531184A/ja active Pending
- 2020-05-01 CA CA3132653A patent/CA3132653A1/en active Pending
- 2020-05-01 BR BR112021021699A patent/BR112021021699A8/pt unknown
-
2021
- 2021-10-28 IL IL287652A patent/IL287652A/en unknown
-
2024
- 2024-07-18 JP JP2024114666A patent/JP2024151337A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109939065B (zh) | 医用水凝胶 | |
| JP6512567B2 (ja) | 経皮投与用ｗｔ１ペプチド癌ワクチン組成物 | |
| CN114369354B (zh) | 用于血管栓塞的可注射水凝胶 | |
| Yi et al. | Injectable temperature-sensitive hydrogel loaded with IL-36Ra for the relief of osteoarthritis | |
| EP3662927A2 (en) | Vaccine composition | |
| JP6512568B2 (ja) | 経皮投与用ｗｔ１ペプチド癌ワクチン組成物 | |
| JP2024151337A (ja) | がんの処置 | |
| JPWO2020223698A5 (https=) | ||
| JPWO2012035598A1 (ja) | 医療用材料、乾燥体及びそれらの製造方法 | |
| JP2014169280A (ja) | 経皮または粘膜投与用ワクチン組成物 | |
| CN116322702A (zh) | 用于癌症治疗的髓源性抑制性细胞功能的免疫调节 | |
| Shen et al. | Tumor immunosuppressive microenvironment modulating hydrogels for second near-infrared photothermal-immunotherapy of cancer | |
| Singh et al. | A review on in vitro—In vivo mucoadhesive strength assessment | |
| CN106432593B (zh) | 一种基于氢键作用的热响应形状记忆水凝胶及其制备方法 | |
| Zhu et al. | PNIPAM hydrogel induces skeletal muscle inflammation response | |
| KR20240139719A (ko) | 폴록사머를 이용한 온도감응성 하이드로겔 조성물 제조 방법 및 이를 이용한 스킨부스터 조성물 | |
| WO2016021601A1 (ja) | 核内受容体リガンドを含む免疫誘導促進用組成物及びワクチン医薬組成物 | |
| EP3975927B1 (en) | Mucoadhesive microgel compositions and methods for using the same | |
| CN116829182A (zh) | 癌症治疗 | |
| JP2014169278A (ja) | 経皮投与用ワクチン組成物 | |
| Huang et al. | Beyond thermal protection: Injectable self-healing chitosan hydrogel in liver tumor thermal ablation | |
| WO2016021602A1 (ja) | 血栓症治療薬を含む液性免疫誘導促進組成物及びワクチン医薬組成物 | |
| Cooper et al. | A polymer network architecture provides superior cushioning and lubrication of soft tissue compared to a linear architecture | |
| CN105517586A (zh) | 适于治疗急性皮肤创伤的水凝胶 | |
| Coucke et al. | Influence of heat treatment on spray-dried mixtures of Amioca® starch and Carbopol® 974P used as carriers for nasal drug delivery |